BioSpace News Archive

Policy

CMIC Joins Align Clinical CRO to Help Develop Open Technology Standards That Streamline Clinical Trials

CMIC Group, a pioneer and a leading CRO in Japan, is pleased to announce that the company joined Align Clinical CRO, a life sciences industry standards group dedicated to creating open technology standards that make it easier for sponsors and contract research organizations to work together during trials.

July 10, 2019
·
2 min read
Deals

Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma

Pan-RAF Program adds an Early Stage, Innovative, Precision Oncology Asset to Jazz Pharmaceuticals’ Growing R&D Portfolio

July 10, 2019
·
5 min read
ABB Robotics to Develop Solutions for the Hospital of the Future

ABB announced that it will introduce collaborative robots to medical laboratories as it opens a new healthcare hub at the Texas Medical Center (TMC) innovation campus in Houston, Texas.

July 10, 2019
·
6 min read
Business

Orexo Signs License and Supply Agreement With Mundipharma for Zubsolv® in Australia and New Zealand

Orexo AB announces the company has signed an agreement granting Mundipharma Pty Limited the exclusive rights to commercialize Orexo’s lead product, Zubsolv®, for the treatment of opioid dependence, in Australia and New Zealand.

July 10, 2019
·
5 min read
Drug Development

ViiV Healthcare Announces Phase III Study Meets Primary Endpoint, Demonstrating the Ability to Control HIV-1 With the 2-drug Regimen Dovato in Virally Suppressed Patients Switching From a TAF-containing, 3-drug Regimen

Week 48 results from the TANGO study will be presented this month at 10th International AIDS Society Conference on HIV Science (IAS 2019)

July 10, 2019
·
8 min read
Top 5 Vendors in the Addison’s Disease Therapeutics Market from 2019 to 2023 | Technavio

The advantages of modified versions over conventional dosage forms are encouraging several companies to focus on developing modified versions of the existing corticosteroid preparations, and oral corticosteroids.

July 10, 2019
·
4 min read
Osivax Secures EUR 8 Million of Financing through a Series A Round to Develop Novel Universal Flu Vaccines and Expand oligoDOM® Technology Platform

Company to establish new subsidiary office in Liege, Belgium

July 10, 2019
·
4 min read
Deals

Dr. Reddy’s to release Q1 FY 20 results on July 29, 2019

Dr. Reddy’s Laboratories Ltd. will announce results for the first quarter ended June 30, 2019 on Monday, July 29, 2019 after the Board Meeting.

July 10, 2019
·
3 min read
BioMidwest

Leading Medical Physics Meeting to Feature More than 40 Presentations on ViewRay’s MRIdian MRI-Guided Radiotherapy

Presentations Highlight MRIdian Clinical Experience with Real-Time On-Table Adaptive Radiotherapy at a Growing Number of Institutions Worldwide

July 10, 2019
·
5 min read
Business

DelMar Announces Relocation of Company Headquarters to San Diego

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel cancer therapies, announced that it has initiated the process of relocating the Company’s headquarters from Vancouver, British Columbia to San Diego, CA.

July 10, 2019
·
4 min read